EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Red Cell and Platelet Indices as Biomarkers of Poor Glycemic Control in Patients With Type 2 Diabetes: A Case‐Control Study

Red Cell and Platelet Indices as Biomarkers of Poor Glycemic Control in Patients With Type 2 Diabetes: Eine Fall-Kontroll-Studie

Helen Owusu-Asante iD, Samuel Nkansah Darko iD, Ebenezer Senu iD, Ezekiel Bonwin Ackah, Max Efui Annani-Akollor

Health Science Reports · 2026-10 · 9 (10)

DOI: 10.1002/hsr2.73382 ↗

Auf einen Blick

Bei 134 Menschen mit Typ-2-Diabetes und 134 Kontrollen war eine schlechte glykämische Kontrolle mit niedrigeren Erythrozytenindizes und höherem MPV verbunden.

Fragestellung

Sind rote Blutbild- und Thrombozytenindizes bei Menschen mit Typ-2-Diabetes mit schlechter glykämischer Kontrolle assoziiert?

Methode

Fall-Kontroll-Studie in Ghana; 134 Menschen mit T2DM und 134 nondiabetische Kontrollen; HbA1c und hämatologische Indizes wurden gemessen; logistisches Vorhersagemodell.

Ergebnisse

Prävalenz schlechter glykämischer Kontrolle: 60,9 %. Niedrigeres Hämoglobin (aOR 0,40; 95 %-KI 0,11–0,78) und Hämatokrit (aOR 0,03; 95 %-KI 0,01–0,92) waren mit geringerer Wahrscheinlichkeit verbunden; höheres MPV mit höherer Wahrscheinlichkeit (aOR 1,15; 95 %-KI 1,02–3,09).

Schlussfolgerung der Autor:innen

Hämoglobin, Hämatokrit und mittleres Plättchenvolumen waren signifikant assoziiert und könnten unabhängige Prädiktoren einer schlechten glykämischen Kontrolle sein.

Kernaussagen

  • 60,9 % der Fälle hatten eine schlechte glykämische Kontrolle
  • Hämoglobin und Hämatokrit waren invers assoziiert
  • MPV war unabhängig mit schlechter Kontrolle assoziiert

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 10.10.2026. Verfasst von Helen Owusu-Asante und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine Kwame Nkrumah University of Science and Technology Kumasi Ghana. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Type 2 diabetes mellitus (T2DM) is associated with systemic inflammation and altered hematological function, including changes in red cell indices and platelet hyperreactivity. While glycosylated hemoglobin (HbA1c) is the gold standard for monitoring glycemic control, its cost and susceptibility to conditions like anemia highlight the need for accessible, reliable alternative biomarkers, particularly for identifying patients with poor glycemic control (HbA1c ≥ 7.0%). This case‐control study, therefore, investigated the utility of red cell and platelet indices as potential biomarkers of poor glycemic control in Ghanaian T2DM patients.

Methods

This study recruited 134 people living with T2DM and 134 nondiabetic controls. Cases were categorized into groups with poor glycemic control (HbA1c ≥ 7.0%) and good glycemic control (HbA1c < 7.0%). HbA1c was measured using an automated analyzer, and hematological indices were measured using a Sysmex XN 2000 analyzer. Statistical analyses were performed in R Language and SPSS version 26 at a significance level of 0.05% and 95% confidence interval employing a logistic prediction model.

Results

Prevalence of poor glycemic control was 60.9%. Cases with poor glycemic control had significantly lower red cell indices such as hemoglobin, hematocrit, red blood cells count, and MCV, but a higher MPV compared to controls ( p < 0.05). Multivariate logistics regression showed increasing hemoglobin levels (aOR: 0.40, 95% CI: [0.11–0.78]; p = 0.0130) and hematocrit (aOR: 0.03, 95% CI: [0.01–0.92]; p = 0.0140) were independently associated with decreased likelihood of poor glycemic control, whiles increasing MPV (aOR: 1.15, 95% CI: [1.02–3.09]; p = 0.0440) demonstrated an independent association with increased likelihood of poor glycemic control.

Conclusion

Hemoglobin level, hematocrit, and mean platelet volume are significantly associated with, and can potentially serve as independent predictors of poor glycemic control. These routine, cost‐effective hematological parameters could be incorporated into risk assessment and management protocols for T2DM in resource‐limited settings.

Schlagwörter

Stichwörter der Autor:innen

diabetesglycemic controlglycosylated hemoglobinhematological indices

Autor:innen und Institutionen

  • Department of Molecular Medicine Kwame Nkrumah University of Science and Technology Kumasi Ghana.
  • Department of Laboratory Technology Kumasi Technical University Kumasi Ghana.

ORCID-Profile: Helen Owusu-Asante, Samuel Nkansah Darko, Ebenezer Senu

Zitieren

APA

Owusu-Asante, H., Darko, S. N., Senu, E., Ackah, E. B., & Annani-Akollor, M. E. (2026). Red Cell and Platelet Indices as Biomarkers of Poor Glycemic Control in Patients With Type 2 Diabetes: A Case‐Control Study. Health Science Reports, 9(10). https://doi.org/10.1002/hsr2.73382

Vancouver

Owusu-Asante H, Darko SN, Senu E, Ackah EB, Annani-Akollor ME. Red Cell and Platelet Indices as Biomarkers of Poor Glycemic Control in Patients With Type 2 Diabetes: A Case‐Control Study. Health Science Reports. 2026;9(10). doi:10.1002/hsr2.73382

BibTeX
@article{OwusuAsante2026,
  author = {Owusu-Asante, Helen and Darko, Samuel Nkansah and Senu, Ebenezer and Ackah, Ezekiel Bonwin and Annani-Akollor, Max Efui},
  title = {Red Cell and Platelet Indices as Biomarkers of Poor Glycemic Control in Patients With Type 2 Diabetes: A Case‐Control Study},
  journal = {Health Science Reports},
  year = {2026},
  volume = {9},
  number = {10},
  doi = {10.1002/hsr2.73382}
}
Kostenlos starten →